Timothy M Mayleben's Net Worth
$11.1 Million
Who is Timothy M Mayleben?
Timothy M Mayleben has an estimated net worth of $11.1 Million. This is based on reported shares across multiple companies, which include NightHawk Radiology Holdings Inc, MARINUS PHARMACEUTICALS, INC., AASTROM BIOSCIENCES INC, Esperion Therapeutics, Inc., Loxo Oncology, Inc., Landos Biopharma, Inc., AKSYS LTD, and ESPERION THERAPEUTICS INC/MI.
SEC CIK
Timothy M Mayleben's CIK is 0001242613
Past Insider Trading and Trends
2019 was Timothy M Mayleben's most active year for acquiring shares with 10 total transactions. Timothy M Mayleben's most active month to acquire stocks was the month of December. 2019 was Timothy M Mayleben's most active year for disposing of shares, totalling 6 transactions. Timothy M Mayleben's most active month to dispose stocks was the month of January. 2011 saw Timothy M Mayleben paying a total of $1,695,381.60 for 751,257 shares, this is the most they've acquired in one year. In 2004 Timothy M Mayleben cashed out on 616,646 shares for a total of $4,423,020.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NightHawk Radiology Holdings Inc No price found
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| +96.04% | 4K |
$16.29 | $65,140.00 | 8.16K |
Aug 15 - Aug 16
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MARINUS PHARMACEUTICALS, INC. (MRNS) Snapshot price: $1.3911
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -43.83% | -8.30K |
—
|
—
| 10.64K |
Oct 10
| |||
Form 4
| +10.42% | 2.3K |
—
|
—
| 24.38K |
Jun 18
| |||
Form 4
| +26.32% | 4.6K |
—
|
—
| 22.07K |
Jan 18
| |||
Form 4
| +25.95% | 3.6K |
—
|
—
| 17.48K |
Jan 26
| |||
Form 4
| +24.72% | 2.75K |
—
|
—
| 13.88K |
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4/A
| +7.76% | 3.3K |
—
|
—
| 45.85K |
Aug 3
| |||
Form 4/A
| +9.81% | 4.5K |
—
|
—
| 50.35K |
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
|
∞
| 42.55K |
$1.04 | $44,252.00 | 42.55K |
Jul 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AASTROM BIOSCIENCES INC (VCEL) Snapshot price: $45.22
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
| +8.13% | 10K |
$2.11 | $21,100.00 | 133K |
Aug 8
| |||
Form 4
| +19.42% | 20K |
$2.36 | $47,200.00 | 123K |
Aug 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
| +26.20% | 21.38K |
$2.12 | $45,364.10 | 103K |
Mar 2 - Mar 3
| |||
Form 4
| +17.24% | 12K |
$2.20 | $26,340.00 | 81.62K |
Nov 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 4
| +32.81% | 17.2K |
$1.45 | $24,940.00 | 69.62K |
Aug 30
| |||
Form 4
| +50.55% | 17.6K |
$1.42 | $24,992.00 | 52.42K |
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +3,939.21% | 33.96K |
$1.46 | $49,605.61 | 34.82K |
Mar 5 - Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
|
∞
| 6.9K |
—
|
—
| 6.9K |
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
| No matching records found | |||||||||
Esperion Therapeutics, Inc. (ESPR) Snapshot price: $1.69
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
| +9.55% | 10.7K |
$2.10 | $22,427.20 | 122.7K |
Dec 30
| |||
Form 4
| +2.28% | 2.5K |
$43.00 | $107,500.00 | 112K |
Mar 11
| |||
Form 4
| +4.78% | 5K |
$49.00 | $245,000.00 | 109.5K |
Feb 28
| |||
Form 4
| +12.64% | 20.84K |
—
|
—
| 185.67K |
Nov 11 - Jan 2
| |||
Form 4
| +6.36% | 5K |
$36.98 | $184,900.00 | 83.66K |
Nov 6
| |||
Form 4
| +10.54% | 7.5K |
$34.55 | $259,106.60 | 78.66K |
Sep 4 - Sep 6
| |||
Form 4
| +7.56% | 5K |
$39.56 | $197,800.00 | 71.16K |
Aug 1
| |||
Form 4
| +8.17% | 5K |
$46.00 | $230,000.00 | 66.16K |
Jun 28
| |||
Form 4
| +8.90% | 5K |
$40.00 | $200,000.00 | 61.16K |
Mar 29
| |||
Form 4
| +9.77% | 5K |
$43.48 | $217,400.00 | 56.16K |
Mar 20
| |||
Form 4
| +10.83% | 5K |
$48.73 | $243,650.00 | 51.16K |
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 28
| |||
Form 4
| +10.93% | 4.55K |
$1.17 | $5,324.55 | 46.16K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +20.22% | 7K |
$14.85 | $103,950.00 | 41.61K |
May 4
| |||
Form 4
| +11.61% | 3.6K |
$15.88 | $57,168.00 | 34.61K |
Jan 27
| |||
Form 4
| +30.23% | 7.2K |
$14.08 | $101,376.00 | 31.01K |
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 4
| +21.00% | 5K |
$14.00 | $70,000.00 | 28.81K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Loxo Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
$100.65 | -$1,577,919.32 |
0
|
Jun 8
| |||
Form 4
| -100.00% | -10.00K |
$80.49 | -$804,948.00 |
0
|
Scheduled
|
Dec 20
| ||
Form 4
|
—
|
0
|
$48.38 | -$164,832.60 | 10K |
Nov 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||